Are we winning the battle in the surgical intensive care unit?

Current Opinion in Critical Care

Volumn 5, Issue 4, 1999, Pages 308-314

  O'Keefe, Grant E ^a   Maier, Ronald V ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007115537     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199908000-00011     Document Type: Article

References (44)

1. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome: Why no magic bullets? Arch Surg 1997; 132:703-707.
2. Naseaway SA: Sepsis research: We must change course. Crit Care Med 1999; 27:427-429.
3. Cohen J, Carlet J: INTERSEPT: An international, multicenter, placebocontrolled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit Care Med 1996; 24:1431-1440.
4. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB: The effects of ibuprofen on the physiology and survival of patients with sepsis. N Eng J Med 1997; 336:912-918.
5. Staubach K-H, Schroder J, Stuber F, Gehrke K, Traumann E, Zabel P: Effect of pentoxifylline in severe sepsis: Results of a randomized, double-blind, placebo-controlled study. Arch Surg 1998; 133:94-100. Pentoxifylline is a phosphodiesterase inhibitor that reduces TNF-α gene transcription. In this preliminary clinical trial, pentoxifylline reduced the severity of organ dysfunction, but did not improve survival. A larger study to determine the effects on clinically relevant outcomes may be warranted.
6. 2 improved survival in comparison to more conventional resuscitation end-points. These results conflict with other recent reports, which do not suggest any benefit from "supraphysiologic" resuscitation endpoints.
7. Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C: Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 1996; 24:517-524.
8. Bender JS, Smith-Meek, MA, Jones CE: Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery. Ann Surg 1997; 226:229-237.
9. Ziegler DW, Wright JG, Choban PS, Flancbaum L: A prospective randomized trial of preoperative "optimization" of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery 1997; 122:584-592.
10. Valentine RJ, Duke ML, Inman MH, Grayburn PA, Hagino RT, Kakish HB, Clagett GP: Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg 1998; 27:203-212. The results of this clinical trial are consistent with those of two other recently published trials and indicate that routine use of pulmonary artery catheter monitoring in the 24 hours prior to abdominal aortic surgery does not reduce complications.
11. Friedman G, Suva E, Vincent J-L: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-2086. The mortality reported in 131 studies of sepsis and septic shock appears to have decreased over the past 40 years. There are a number of potential explanations, ranging from changes in case definitions to changing site and severity of the infections.
12. Charalambous C, Swoboda SM, Dick, J, Pert, Lipsett PA: Risk factors and clinical impact of central line infections in the surgical intensive care unit. Arch Surg 1998; 133:1241-1246. This retrospective study proposed to examine the risk factors for positive central venous catheter cultures and the clinical consequences of a positive catheter culture. Blood cultures were positive with the same organism in 45% of catheters with > 15 colonies on semiquantitative culture. This study suggests that bacteremia secondary to central venous catheter infections is frequent and mortality is approximately 20%.
13. Mullins RJ, Veum-Stone J, Helfand M, Zimmer-Gembeck M, Hedges JR, Southard PA, Trunkey DD: Outcome of hospitalized injured patients after institution of a trauma system in an urban area. JAMA 1994; 217(24):1919-1924
14. Mullins RJ, Mann NC, Hedges JR, Worrall W, Jurkovich GJ: Preferential benefit of implementation of a statewide trauma system in one of two adjacent states. J Trauma 1998; 44:609-617. This study supports the authors' previous report that the establishment of an organized trauma system improves outcomes. In this case, improvements in trauma case fatality rates were compared between Oregon and Washington states, and a greater improvement was found in Oregon, consistent with a beneficial impact of trauma system establishment.
15. O'Keefe GE, Jurkovich GJ, Copass M, Maier RV: Ten year trend in survival and resource utilization at a level I trauma center, Ann Surg, 1999;229: 409-415. This study of mortality and resource utilization at a single level I trauma center suggests that survival outcome in patients with an ISS ≥16 has improved over time. This improvement is potentially related to increased experience with trauma, and could not be attributed to any specific intervention.
16. Tepas JJ III, Patel JC, DiScala C, Wears RL, Veldenz HC: Relationship of trauma patient volume to outcome experience: Can a relationship be defined? J Trauma 1998; 44:827-831. This report suggests that survival outcome in the most severely injured pediatric trauma patients is worse at the higher volume trauma centers. The authors suggest that high volume puts excessive stress on available resources and compromises care and outcomes. Although the results must be carefully interpreted because there was little adjustment for injury severity in the analyses, the points raised are important. Trauma systems and centers must assure availability of resources to maximize survival.
17. O'Keefe GE, Maier RV, Diehr P, Grossman D, Jurkovich GJ, Conrad D: The complications of trauma and their associated costs in a level I trauma center Arch Surg. 1997;132:920-924.
18. Gentilello LM, Jurkovich GJ, Stark MS, Hassantash SA, O'Keefe GE: Is hypothermia in the victim of major trauma protective or harmful? Ann Surg 1997; 226:439-449.
19. Merrell SW, Saffle JR, Sullivan JJ, Larsen CM, Warden GD: Increased survival after thermal injury: A nine year review. Am J Surg 1987; 154: 623-627.
20. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967; 319-323.
21. Abel SJC, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW: Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998; 53:292-294. A comparison between cohorts of patients with ARDS from consecutive time periods from 1990-1997 indicated that there was a significant reduction in mortality from 66% in the initial 3 years to 34% in the subsequent 4 years. The authors were unable to attribute this reduction in mortality to any changes in patient demographics or underlying causes of ARDS. However, multivariate analysis was not performed, and it may be that the decrease in mortality was due to a reduction in disease severity or case mix. Although the use of inverse ratio mechanical ventilation was increased in the second time period, the authors were careful not to attribute the reduction in mortality to this therapy. They concluded that the improvement in survival was likely due to general improvements in care over time.
22. Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with acute respiratory distress syndrome (ARDS) 1983-1993. JAMA 1995; 273:306-309.
23. 2 were all significantly higher than in the conventional group.
24. Stewart TE, Meade MO, Cook DJ, Granton GT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, Todd TRJ, Slutsky AS: Evaluation of a ventilation strategy to prevent barotrauma in patients at high for acute respiratory distress syndrome. N Engl J Med 1998; 338:355-361. This clinical trial suggests that limiting peak inspiratory pressures and allowing hypercarbia is of no benefit in patients at risk for ARDS. The differences In study design between this study and the study reported by Amato et al. [23••] warrant careful review of each of these studies.
25. Maier RV, Mitchell D, Gentilello L: Optimal therapy for stress gastritis. Annals of Surgery 1994; 220:353-363.
26. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M: Stress ulcer prophylaxis in critically ill patients: Resolving discordant meta-analyses. JAMA 1996; 275:308-314.
27. Cook DJ, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338:791-797. This important clinical trial suggests that ranitidine is more effective than sucralfate in preventing upper gastrointestinal bleeding. Despite the rigorous design, analysis and reporting, this study is limited by failing to document the actual site of bleeding in a majority of patients with bleeding. Ranitidine was no more effective when only patients with documented stress ulceration were included.
28. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, Kunches LM, Farber HW, Wedel SM, McCabe WR: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: The role of gastric colonization. N Engl J Med 1987; 317:1376-1382
29. Ephgrave KS, Kleiman-Wexler R, Pfaller M, Booth BM, Reed D, Werkmeister L, Young S: Effects of sucralfate vs antacids on gastric pathogens. Arch Surg 1998; 133:251-257.
30. Lam NP, Le PDT, Le P-DT, Crawford SY, Patel S: National survey of stress ulcer prophylaxis. Crit Care Med 1999;27:98-103.
31. Nielsen HJ, Nielsen H, Jensen S, Moesgarrd F: Ranitidine improves postoperative monocyte and neutrophil function. Arch Surg, 1994; 129: 309-315.
32. O'Keefe GE, Gentilello LM, Maier RV: The impact of histamine-2 receptor antagonists upon infectious complications in critically ill trauma patients. Ann Surg, 1998; 227:120-125. This study presents data from a clinical trial comparing ranitidine with sucralfate stress ulceration prophylaxis in trauma victims. There was an increase in total infectious complications with ranitidine use, suggesting a potential adverse systemic (immunologic) effect. These results contrast with previous reports that suggest a beneficial immunologic effect of ranitidine in post-operative patients or victims of traumatic brain injury.
33. Peddicord TE, Olsen KM, Collier DS: Effect of omeprazole, iansoprazole, and ranitidine on the DNA synthesis of mononuclear cell, Crit Care Med 1999;27:90-94. Ranitidine increases DNA synthesis in peripheral blood mononuclear cells in comparison to omeprazole and lansoprazole. While this supports a potential immunologic effect, it is not certain whether this is immune-enhancing or immune-suppressive.
34. Delinger, EP: Surgical Infections: Diagnosis and Treatment. In Scientific American Medicine. Edited by Meakins, JL. New York: Scientific American, Inc. 1994.
35. Naziri W, Cheadle WG, Pietsch JD, Appel S, Polk HC, Jr: Pneumonia in the surgical intensive care unit: Immunologic keys to the silent epidemic. Ann Surg 1994; 219:632-642.
36. Trouillet J-L, Chastre J, Vuagnat A, Joly-Guillou, M-L: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539. The results of this study suggest that use of antibiotics, particularly broad-spectrum agents, contributes to the development of VAP with resistant organisms.
37. O'Keefe, GE, Jurkovich GJ, Maier RV; Defining excess resource utilization and identifying associated factors for trauma victims. J Trauma 1999; 46:473-478. This report documents a strong association between complications (eg, ARDS, pneumonia) and resource utilization, and suggests that prolonged length of stay can be attributed to complications. Mortality in patients with complications and prolonged length of stay was extremely low. It was suggested that complications and excessive length of stay could be used as important outcome measures after trauma.
38. Fagon J-Y, Chastre J, Vuagnat A, Trouillet J-L, Novara A, Gibert C: Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869.
39. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, Gibert C: Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157:1165-1172. This report confirms the results of previous work and indicates a 55% incidence of pneumonia in patients with ARDS. The diagnosis was based on specimens obtained with bronchoscopy. A high incidence of methicillin-resistant Staphylococcus aureus was reported to be associated with previous antibiotic use.
40. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C: Incidence of and risk factors for ventilator-assisted pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-440.
41. Luiten EJ, Hop WCJ, Lange JF, Bruining HA: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222:57-65.
42. Verwaest C, Verhaegen J, Ferdinande P, Schetz M, Van den Berghe G, Verbist L, Lauwers P: Randomized, controlled trial of seloctive digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997; 25:63-71.
43. D'Amico R., Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A: Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316:1275-1285. This meta-analysis was unique in that the authors obtained original data from a number of the reported studies, in addition to the more typical meta-analysis. Their analyses suggest that respiratory tract infections and mortality can be reduced in unselected ICU patients by a combination of systemic and topical antibiotic prophylaxis.
44. Ramsey G, van Saene RHKF: Selective gut decontamination in intensive care and surgical practice: Where are we? World J Surg 1998; 22:164-170.